ARMP
ARMP
AMEX · Biotechnology

Armata Pharmaceuticals Inc

$3.67
+0.08 (+2.23%)
As of Oct 3, 2:14 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +375.5% upside
Low Target $10.78
Average Target $17.45
High Target $19.60
Current Price $3.67
Current
$3.67
Target
$17.45
$10.78 $17.45 avg $19.60
Scenario Analysis
Bear Case
$10.78
193.7%
Low target
Base Case
$17.45
+375.5%
Avg target
Bull Case
$19.60
+434.1%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$16.34
-77.5% from high
52-Week Low
$2.94
+24.8% from low
Target vs 52W High
$17.45
+6.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.0%
AMGN
Amgen Inc
Hold 43 47% $190.87 -52.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +150.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -13.2%
MRNA
Moderna Inc
Hold 30 37% $149.45 -21.3%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.8%